Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00284453 · ClinicalTrials.gov registry record
Ventricular Tachyarrhythmia (VT) Storm, Gene Expression in Implantable Cardioverter Defibrillator (ICD) Patients With Electrical Storm
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 65
- Enrollment target
NCT00284453 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 65 participants.
The verdict
NCT00284453 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 65 participants
- Enrollment target
Study Summary
The purpose of the proposed pilot study is to identify factors which are associated with periods of high ventricular arrhythmia burden. This will be performed by analysis of gene expression from peripheral blood samples.
Interventions
- PROCEDURE Peripheral blood sampling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2008-08-26 |
| Est. Completion | 2018-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00284453
The ClinicalTrials.gov registry entry for NCT00284453 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Peripheral blood sampling is the first listed.
NCT00284453 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00284453 about?
NCT00284453 is a clinical study titled "Ventricular Tachyarrhythmia (VT) Storm, Gene Expression in Implantable Cardioverter Defibrillator (ICD) Patients With Electrical Storm". The purpose of the proposed pilot study is to identify factors which are associated with periods of high ventricular arrhythmia burden. This will be performed by analysis of gene expression from peripheral blood samples.
What is the current status of trial NCT00284453?
This trial is currently completed. The enrollment target is 65 participants. The study started on 2008-08-26. Estimated completion is 2018-12.
What interventions are being tested in trial NCT00284453?
The interventions under investigation include: Peripheral blood sampling (PROCEDURE).
Who is sponsoring clinical trial NCT00284453?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.